BIO-TECHNE CORP's ticker is TECH and the CUSIP is 09073M104. A total of 431 filers reported holding BIO-TECHNE CORP in Q4 2020. The put-call ratio across all filers is 1.11 and the average weighting 0.2%.
About BIO-TECHNE CORP
Bio-Techne Corp is a leading provider of innovative life science research tools and diagnostic solutions. The company is headquartered in Minneapolis, Minnesota, and has operations in over 50 countries worldwide. Bio-Techne's products and services are used by researchers and clinicians in a wide range of fields, including cancer research, stem cell research, and immunology.
Bio-Techne's success is due in large part to its commitment to innovation and customer service. The company invests heavily in research and development, and has a team of over 1,000 scientists working to develop new products and technologies. Bio-Techne also has a strong focus on customer service, with a dedicated team of technical support specialists available to assist customers with any questions or issues they may have.
In addition to its research tools and diagnostic solutions, Bio-Techne also has a growing portfolio of clinical diagnostic products. The company's Exosome Diagnostics subsidiary is a leader in the development of liquid biopsy tests for cancer diagnosis and monitoring.
Bio-Techne's leadership team is comprised of experienced executives with a track record of success in the life sciences industry. Charles Kummeth, the company's CEO, has been with Bio-Techne since 2013 and has overseen significant growth and expansion during his tenure.
Overall, Bio-Techne is a company with a strong reputation for innovation, customer service, and leadership in the life sciences industry. With a growing portfolio of products and services, the company is well-positioned for continued success in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $4,296,000 | +6.8% | 8,304 | 0.0% | 0.27% | +0.8% |
| Q3 2021 | $4,024,000 | +0.5% | 8,304 | 0.0% | 0.26% | +7.3% |
| Q2 2021 | $4,005,000 | +26.1% | 8,304 | -0.2% | 0.25% | +28.0% |
| Q1 2021 | $3,177,000 | +19.1% | 8,318 | -1.0% | 0.19% | +15.6% |
| Q4 2020 | $2,668,000 | +28.1% | 8,403 | -0.1% | 0.17% | +16.8% |
| Q3 2020 | $2,083,000 | -2.4% | 8,408 | 0.0% | 0.14% | -7.7% |
| Q2 2020 | $2,134,000 | +32.4% | 8,408 | -1.1% | 0.16% | +14.8% |
| Q1 2020 | $1,612,000 | -13.6% | 8,499 | +0.0% | 0.14% | +11.6% |
| Q4 2019 | $1,865,000 | +11.6% | 8,498 | -0.5% | 0.12% | +1.7% |
| Q3 2019 | $1,671,000 | -6.1% | 8,538 | 0.0% | 0.12% | -4.8% |
| Q2 2019 | $1,780,000 | +5.0% | 8,538 | 0.0% | 0.12% | +3.3% |
| Q1 2019 | $1,695,000 | +36.8% | 8,538 | -0.2% | 0.12% | +34.4% |
| Q4 2018 | $1,239,000 | -19.8% | 8,558 | -0.2% | 0.09% | -4.3% |
| Q3 2018 | $1,544,000 | -33.9% | 8,578 | -45.7% | 0.09% | -36.5% |
| Q2 2018 | $2,337,000 | -29.7% | 15,800 | -28.2% | 0.15% | -26.7% |
| Q1 2018 | $3,323,000 | +10.9% | 21,996 | -4.9% | 0.20% | +17.4% |
| Q4 2017 | $2,996,000 | +179.5% | 23,125 | +160.8% | 0.17% | +173.0% |
| Q3 2017 | $1,072,000 | +3.1% | 8,868 | 0.0% | 0.06% | +16.7% |
| Q2 2017 | $1,040,000 | +15.4% | 8,868 | 0.0% | 0.05% | +17.4% |
| Q1 2017 | $901,000 | -2.4% | 8,868 | -1.2% | 0.05% | -4.2% |
| Q4 2016 | $923,000 | -3.8% | 8,974 | +2.5% | 0.05% | 0.0% |
| Q3 2016 | $959,000 | -4.3% | 8,758 | -1.5% | 0.05% | -2.0% |
| Q2 2016 | $1,002,000 | +19.3% | 8,889 | 0.0% | 0.05% | +19.5% |
| Q1 2016 | $840,000 | +5.0% | 8,889 | 0.0% | 0.04% | +5.1% |
| Q4 2015 | $800,000 | -2.7% | 8,889 | -0.0% | 0.04% | -7.1% |
| Q3 2015 | $822,000 | -6.4% | 8,893 | -0.3% | 0.04% | +5.0% |
| Q2 2015 | $878,000 | -1.8% | 8,918 | 0.0% | 0.04% | +11.1% |
| Q1 2015 | $894,000 | – | 8,918 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadcrest Asset Management, LLC | 275,000 | $18,719,250 | 20.14% |
| Montanaro Asset Management Ltd | 408,800 | $27,827,016 | 4.90% |
| Sandhill Capital Partners LLC | 613,061 | $41,731,091 | 3.90% |
| Pembroke Management, LTD | 365,611 | $24,887,141 | 3.40% |
| DF DENT & CO INC | 3,349,047 | $227,969,648 | 3.34% |
| Brown Capital Management | 3,158,004 | $214,965,332 | 3.30% |
| Ownership Capital B.V. | 1,786,273 | $121,591,603 | 3.05% |
| STONE RUN CAPITAL, LLC | 86,335 | $5,876,823 | 2.88% |
| Jackson Square Partners, LLC | 1,260,547 | $85,805,434 | 2.87% |
| Summit Creek Advisors LLC | 284,681 | $19,378,236 | 2.64% |